- J Thorac Dis
- v.5(5); Oct 2013
- PMC3815723
J Thorac Dis. 2013 October; 5(5): 667–677.
PMCID: PMC3815723
Chinese guideline for the prevention and management of bronchial asthma (Primary Health Care Version)
Asthma Workgroup, Chinese Thoracic Society, and Chinese Societ of General Practitioners
Bronchial asthma (hereinafter referred to as asthma) is one of common chronic respiratory diseases, and its global prevalence has been on the rise over the recent years. Clinical studies and practices show that standardized diagnosis and treatment, plus practically effective management, are important to achieve better asthma control and quality of life. The Asthma Workgroup, Chinese Thoracic Society, revised the Chinese Guidelines for Prevention and Treatment of Bronchial Asthma (hereinafter referred to as the Guidelines) twice, in 2003 and 2008. Overall, the Guidelines contributed substantially to the progress of prevention and treatment of bronchial asthma in China. However, owing to a variety of factors (such as shortage in measurement devices and asthma medications, under-developed system of medical education) in primary health-care institutions, the Guidelines have not been well adapted and fully implemented in these settings which are believed to be the vanguards in asthma prevention and treatment. In this regard, there is a dire need to release a primary health care version of these Guidelines which are well compatible with specific practices at community-level medical settings in China.
The Asthma Workgroup, Chinese Thoracic Society, in collaboration with the CMA Society of General Practitioners, has convened a panel of experts in related fields to discuss and develop a version of the Guideline for primary health care professionals (Primary Health Care Version) with the aim to standardize the diagnosis and treatment of asthma and to raise the awareness of asthma prevention in the community level.
No comments:
Post a Comment